Original drug products approved by the Food and Drug Administration (Center for Drug Evaluation and Research) in 2025

The annual review of new drugs approved by the FDA is an important tool for analyzing current trends in pharmacology and medicine, reflecting progress in the treatment of complex diseases, including oncological pathologies, orphan diseases, and infectious processes. The article aims to inform medica...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	D. V. Kurkin, N. A. Osadchenko, D. A. Galkina, D. A. Bakulin, Yu. G. Ustyakina, S. A. Voskresensky, A. R. Makarova, O. V. Shatalova, A. V. Strygin, V. I. Petrov, O. V. Marincheva, Yu. V. Gorbunova, K. N. Koryanova, E. S. Mishchenko, I. Sh. Gadaev, L. I. Shcherbakova, I. N. Dyakova, E. I. Morkovin, A. S. Shuvaeva
Format:	Artigo
Sprache:	Russo
Veröffentlicht:	Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute 2026-06-01
Schriftenreihe:	Фармация и фармакология (Пятигорск)
Schlagworte:	fda оригинальные препараты иммунотерапия малые молекулы биопрепараты препараты для лечения орфанных болезней
Online-Zugang:	https://www.pharmpharm.ru/jour/article/view/1895
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!